Gynecomastia - A difficult diagnostic problem

Endokrynologia Polska

Volumn 62, Issue 2, 2011, Pages 190-201

  Derkacz, Marek ^a   Chmiel Perzyńska, Iwona ^a   Nowakowski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Diagnosis; Etiopathogenesis; Gynecomastia; Psychosocial problem

Indexed keywords

8 PRENYLNARINGENIN; AMPHETAMINE; ANDROGEN; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BICALUTAMIDE; CANNABIS; CYPROTERONE; DIAMORPHINE; DIDANOSINE; EFAVIRENZ; ESTROGEN; ESTROGEN DERIVATIVE; ETHIONAMIDE; FINASTERIDE; FLUTAMIDE; GENISTEIN; GONADOTROPIN; HORMONE; ISONIAZID; KETOCONAZOLE; METRONIDAZOLE; PHYTOESTROGEN; PROLACTIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOESTROGEN;

ADOLESCENCE; ADRENAL GLAND; ADRENAL TUMOR; ALCOHOLISM; AROMATASE EXCESS SYNDROME; BREAST CANCER; BREAST HYPERPLASIA; BREAST MALFORMATION; CANNABIS ADDICTION; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MECHANISM; ECHOGRAPHY; ENDOCRINE BREAST DISEASE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN PRODUCING TUMOR OF ADRENAL GLAND; FALSE GYNECOMASTIA; GENETIC DISORDER; GYNECOMASTIA; HEROIN DEPENDENCE; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; IDIOPATHIC GYNECOMASTIA; INFANCY; KARYOTYPE 46,XX; KARYOTYPE 47,XXY; KIDNEY DISEASE; KLINEFELTER SYNDROME; LIPOMASTIA; LIVER CIRRHOSIS; LIVER DISEASE; MAMMOGRAPHY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PATHOLOGICAL GYNECOMASTIA; PHYSICAL EXAMINATION; PHYSIOLOGICAL GYNECOMASTIA; PROLACTIN BLOOD LEVEL; PROSTATE CANCER; PSEUDOGYNECOMASTIA; REFEEDING SYNDROME; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SENESCENCE; SENSITIVITY AND SPECIFICITY; SOCIAL PSYCHOLOGY; SPINAL CORD INJURY; STEATOMASTIA; STRESS; SYMPTOM; TESTIS CANCER; TESTIS DISEASE; THERMOGRAPHY;

ADOLESCENT; ADULT; ANDROGENS; DIAGNOSIS, DIFFERENTIAL; ESTROGENS; GYNECOMASTIA; HUMANS; MALE;

EID: 79958001542     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Bannayan GA, Hajdu SI. Gynecomastia: a clinicopathologic study of 351 cases. Am J Clin Pathol 1972; 57: 431-437.
2. Braunstein GD. Gynecomastia. N Engl J Med 1993; 328: 490-495.
3. Bembo SA, Carlson HE. Gynecomastia: its features, and when and how to treat it. Cleve Clin J Med 2004; 71: 511-517. (Pubitemid 38832615)
4. Niewoehner CB, Nurtal FQ. Gynecomastia in a hospitalized male population. Am J Med 1984; 77: 633-638.
5. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
6. Moore GF, Wattenberg CA, Rose DK Breast changes due to diethylstilbestrol. JAMA 1945; 127: 60-62.
7. Ando S, DeAmicis F, Rago V et al. Breast cancer: from estrogen to androgen receptor. Mol Cell Endocrinol 2002; 193: 121-128. (Pubitemid 34823616)
8. Rochefort H, Garcia M. The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 1983; 23: 193-216. (Pubitemid 14184959)
9. Carlson HE. Gynecomastia. In: Morley JE, Korenman SG (eds.). Endocrinology and Metabolism in the Elderly. Blackwell Scientific Publications Inc, Boston 1992: 294-307.
10. Nordt CA, DiVasta AD. Gynecomastia in adolescents. Curr Opin Pediatr 2008; 20: 375-382.
11. Carlson HE, Kane P, Lei ZM et al. Presence of luteinizing hormone/human chorionic gonadotropin receptors in male breast tissues. J Clin Endocrinol Metab 2004; 89: 4119-4123. (Pubitemid 39071521)
12. Turkington RW. Serum prolactin levels in patients with gynecomastia. J Clin Endocrinol Metab 1972; 34: 62-66.
13. Ng ST, Zhou J, Adesanya OO et al. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 1997; 10: 1141-1144.
14. Dundar B, Dundar N, Erci T et al. Leptin levels in boys with pubertal gynecomastia. J Pediatr Endocrinol Metab 2005; 18: 929-934. (Pubitemid 41749098)
15. Cho YR, Jones S, Gosain AK. Neurofibromatosis: a cause of prepubertal gynecomastia. Plast Reconstr Surg 2008; 121: 34e-40e.
16. Gray A, Feldman HA, McKinley JB et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab 1991; 73: 1016-1025. (Pubitemid 21901140)
17. Ismail AAA, Barth JH. Endocrinology of gynaecomastia. Ann Clin Biochem 2001; 38: 596-607. (Pubitemid 33702267)
18. Czajka-Oraniec I, Zgliczyński W. Fenotyp pacjentów z ginekomastia̧. Endokrynol Pol 2008; 59: 131-139.
19. Ersöz H, Onde ME, Terekeci H et al. Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. Int J Androl 2002; 25: 312-316.
20. Griffin J, Wilson J. The syndrome of androgen resistance. N Engl J Med 1980; 302: 198-209.
21. Bular J, Mowszowicz I, Schaison G. Increased aromatase activity in pubie skin fibroblasts from patients with isolated gynaecomastia. J Clin Endocrinol Metab 1987; 64: 618-623. (Pubitemid 17020933)
22. Eckman A, Dobs A. Drug-induced gynecomastia. Expert Opin Drug Saf 2008; 7: 691-702.
23. Prisant LM, Chin E. Gynecomastia and hypertension. J Clin Hypertens (Greenwich) 2005; 7: 245-248.
24. Mosenkis A, Townsend RR. Gynecomastia and antihypertensive therapy. J Clin Hypertens (Greenwich) 2004; 8: 469-470.
25. Brannstein GD. Gynecomastia. NEJM 1993; 328: 490-495.
26. Krause W. Teratogenic damage to the male genital organs. Fortschr Med 1976; 94: 1673-1675.
27. Zochling J, Large G, Fassett R. Gynaecomastia and amlodipine. Med J Aust 1994; 160: 807.
28. Peyriere H, Mauboussin JM, Rounet I et al. Report of gynecomastia in five male patients during antiretroviral therapy for HIV infection. AIDS 1999; 13: 2167-2169. (Pubitemid 29509596)
29. Komine N, Takeda Y, Nakamata T. Amlodipine-induced gynecomastia in two patients on long-term hemodialysis therapy. Clin Exp Nephrol 2003; 7: 85-86. (Pubitemid 36460549)
30. Carmichael AJ, Paul CJ. Reversible gynaecomastia associated with etritinate. Br J Dermatol 1989; 120: 317. (Pubitemid 19055432)
31. Reid DM, Martynoga AG, Nuki G. Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed) 1982; 285: 1083-1084. (Pubitemid 12029695)
32. Salliere D, Clerc D, Bisson M et al. Transient gynecomastia during treatment with D-penicillamine. Presse Med 1984; 37: 2265.
33. Donovan B, Bodsworth NJ, Mulhall BP et al. Gynaecomastia associated with saquinavir therapy. Int J STD AIDS 1999; 10: 49-50.
34. García Rodríguez LA, Jick H. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 1994; 308: 503-506. Erratum in: BMJ 1994 26; 308: 819.
35. Allen RC, Wallace AM, Royce M. Marinol-induced gynecomastia: a case report. Am J Med 2007; 120: e1.
36. Jelenkovic AV, Macukanovic-Golubovic LD. Diazepam-associated gynecomastia. Ann Pharmacother 2005; 39: 201.
37. Gardette V, Vezzosi D, Maiza JC et al. Gynecomastia associated with fenofibrate. Ann Pharmacother 2007; 41: 508-510.
38. Schmutz JL, Barbaud A, Tréchot P. Fenofibrates and gynaecomastia. Ann Dermatol Venereol 2008; 135: 437.
39. Oteri A, Catania MA, Travaglini R et al. Gynecomastia possibly induced by rosuvastatin. Pharmacotherapy 2008; 28: 549-551.
40. Boulenger A, Viseux V, Plantin-Eon I et al. Gynaecomastia following treatment by fluoxetine. J Eur Acad Dermatol Venereol 2003; 17: 109.
41. Navarro-González M, Alberdi-Leniz A, Gené-Badia J. Gynecomastia by mirtazapin Med Clin (Barc) 2006; 127: 37-38.
42. Damsa C, Sterck R, Schulz P. Case of gynecomastia during paroxetine therapy. J Clin Psychiatry 2003; 64: 971.
43. Sahin M, Yilmaz H, Guvener ND. A possible case of gynecomastia with fluoxetine. Ann Pharmacother 2005; 39: 1369.
44. Mendhekar DN, Andrade CR. Unilateral gynecomastia induced by risperidone in a geriatric male patient. Indian J Med Sci 2005; 59: 361-362. (Pubitemid 41247015)
45. Hammons KB, Edwards RF, Rice WY. Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy 2006; 26: 1165-1168.
46. Haddad E. Management of gynecomastia induced by bicalutamide. Ann Urol (Paris) 2006; 40: S49-S52. (Pubitemid 46839230)
47. Dixit R, Sharma S, Nawal CL. Gynaecomastia during antituberculosis chemotherapy with isoniazid. J Assoc Physicians India 2008; 56: 390-391.
48. Khanna P, Panjabi C, Maurya V et al. Isoniazid associated, painful, bilateral gynaecomastia. Indian J Chest Dis Allied Sci 2003; 45: 277-279.
49. Caocci G, Atzeni S, Orrù N et al. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia. Leukemia 2008; 22: 2127-2128.
50. van der Steen M, Du Caju MV, Van Acker KJ. Gynecomastia in a male infant given domperidone. Lancet 1982,16: 884-885. (Pubitemid 12018571)
51. Abe K, Mitsuka T, Kanamori S et al. Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis. Mod Rheumatol 2007; 17: 511-513.
52. Karakurt F, Kargili A, Uz B et al. Venlafaxine-induced gynecomastia in a young patient: a case report. Clin Neuropharmacol 2009; 32: 51-52.
53. Mira JA, Lozano F, Santos J et al. Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment. Antivir Ther 2004; 9: 511-517. (Pubitemid 39150208)
54. Aquilina C, Viraben R. Gynaecomastia in a male patient during stavudine and didanosine treatment for HIV infection. Int J STD AIDS 2001; 12: 481-482. (Pubitemid 32656061)
55. Andersson AM, Skakkebaek NE. Exposure to exogenous estrogens in food: possible impact on human development and health. Eur J Endocrinol 1999; 140: 477-485. (Pubitemid 29314708)
56. Czupryńska K. Marchlewicz M., Wiszniewska B. Wpływ ksenoestrogenów na mȩski układ płciowy. Postȩpy biologii komórki 2007; 34: 317-333.
57. Martinez J, Lewi JE. An unusual case of gynecomastia associated with soy product consumption. Endocr Pract 2008; 14: 415-418.
58. Wood CE, Appt SE, Clarkson TB et al. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Reprod 2006; 75: 477-486. (Pubitemid 44268082)
59. Perry DL, Spedick JM, McCoy TP et al. Dietary soy protein containing isoflavonoids does not adversely affect the reproductive tract of male cynomolgus macaques (macaca fascicularis).J Nutr 2007; 137: 1390-1394. (Pubitemid 46855475)
60. Felner EI, White PC. Prepubertal gynecomastia: indirect exposure to estrogen cream. Pediatrics 2000; 105: E55.
61. Edidin DV, Levitsky LL. Prepubertal gynecomastia associated with estrogen-containing hair cream. Am J Dis Child 1982; 136: 587-588. (Pubitemid 12075621)
62. Kurtz JL. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007; 356: 2542-2543. author reply 2543-2544.
63. Sahin M, Yilmaz H, Gursoy A et al. Gynaecomastia in a man and hyperoestrogenism in a woman due to ingestion of nettle (urtica dioica). N Z Med J 2007; 120: U28.
64. Goh SY, Loh KC. Gynaecomastia and the herbal tonic "Dong Quai". Singapore Med J 2001; 42: 115-116.
65. Kiong HN. Article: gynaecomastia and the herbal tonic "Dong Quai". Singapore Med J 2001; 42: 286-287.
66. Jameel JK, Kneeshaw PJ, Rao VS et al. Gynaecomastia and the plant product "Tribulis terrestris". Breast 2004; 13: 428-430.
67. Brody SA, Loriaux DL. Epidemic of gynecomastia among Haitian refugees: exposure to an environmental antiandrogen. Endocr Pract 2003; 9: 370-375.
68. Heufelder AE, Leinung MC, Northcutt RC. Holiday gynecomastia. Ann Intern Med 1992; 116: 877.
69. Rosenblum ER, van Thiel DH, Campbell IM. Separation and identification of phyto-estrogenic compounds isolated from bourbon. Alcohol Alcohol 1987; 1: 551-555.
70. North RH, Walter RM Jr. The effects of alcohol on the endocrine system. Med Clin North Am 1984; 68: 133-146.
71. Fara GM, Del-Corvo G, Bernuzzi S et al. Epidemic of breast enlargement in an Italian school. Lancet. 1979; 2: 295-297.
72. Coutslon F, Wills JH. Epidemiological studies relating to the use of hormonal agents in animal production. Enviro Qua! Saf Suppl 1976; 5: 238-252.
73. Dardick KR. Holiday gynecomastia related to marijuana? Ann Intern Med 1993; 119: 253.
74. Harmon J, Aliapoulios MA. Gynecomastia in marijuana users. N Engl J Med 1972; 287: 936.
75. Harmon JW, Aliapoulios MA. Marijuana-induced gynecomastia: clinical and laboratory experience. Surgical Forum 1974; 25: 423-425.
76. Cates W Jr, Pope JN. Gynecomastia and cannabis smoking. A nonassociation among US Army soldiers. Am J Surg. 1977; 134: 613-615. (Pubitemid 8229979)
77. Heufelder AE, Leinung MC, Northcutt RC. Holiday gynecomastia. Annals of Internal Medicine 1992; 116; 10 877.
78. Zayed A, Stock JL, Liepman MK et al. Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma. J Endocrinol Invest 1994; 17: 275-278.
79. Lanigan D, Choa RG, Evans J. A feminizing adrenocortical carcinoma presenting with gynaecomastia. Postgrad Med J 1993; 69: 481-483. (Pubitemid 23193988)
80. Korenman SG. The endocrinology of the abnormal male breast. Ann NY Acad Sci 1986; 464: 400-408.
81. Mohammed Ilyas MI, Turner GD, Cranston D. Human chorionic gonadotropin-secreting clear cell renal cell carcinoma with paraneoplastic gynaecomastia. Scand J Urol Nephrol 2008; 42: 555-557.
82. Yaturu S, Harrara E, Nopajaroonsri C et al. Gynecomastia attributable to human chorionic gonadotropin-secreting giant cell carcinoma of lung. Endocr Pract 2003; 9: 233-235.
83. Caron P, A verous S, Combelles JL et al. Gynecomastia and cancer of the bladder: an ectopic secretion of chorionic gonadotropin hormone. Ann Urol (Paris) 1984; 18: 42-44.
84. Wurzel RS, Yamase HT, Nieh PT. Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract. J Urol 1987; 137: 502-504. (Pubitemid 17028295)
85. Berkovitz GD, Guerami A, Brown TR et al. Familial gynaecomastia with increased extraglandular aromatization of plasma carbon-19 steroid. Clin Invest 1985; 75: 1763-1966.
86. Wallach EE, Garcia CR. Familial gynaecomastia without hypogonadism: a report of three cases in one family. J Clin Endocrinol Metab 1962; 22: 1201-1206.
87. Hemsell DL, Edman CD, Marks JF et al. Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. Clin Invest 1977; 60: 455-464. (Pubitemid 8154154)
88. Farag TI, Iskandar A. Tutankamun's paternity. J R Soc Med 1998; 91: 291-292.
89. Reeves N. The Complete Tutankamun. American University in Cairo Press, Cairo 1990.
90. Nunn JF. Ancient Egyptian Medicine. British Museum Press, London 1996.
91. Tiulpakov A, Kalintchenko N, Semitcheva T et al. A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome. J Clin Endocr Metab 2005; 90: 4184-4190. (Pubitemid 41058195)
92. Conte FA, Grumbach MM, Ito Y et al. A syndrome of female pseudohermaphroditism hypergonadotrophic hypogonadism and multi-cystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994; 78: 1287-1292. (Pubitemid 24180993)
93. Stratakis CA, Vottero A, Brodie A et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 1998; 83: 1348-1357. (Pubitemid 28496419)
94. Blackett PR, Freeman DA. Androstenedione aromatization as a cause of gynecomastia in 11beta-hydroxylase and 21-hydroxylase deficiencies. Endocr Pract 1996; 2: 90-93.
95. Wasniewska M, Raiola G, Galati MC et al. Non-classical 21-hydroxylase deficiency in boys with prepubertal or pubertal gynecomastia. Eur J Pediatr 2008; 167: 1083-1084.
96. Korenman SG. The endocrinology of the abnormal male breast. Ann NY Acad Sci 1986; 464: 400-408.
97. Aksglaede L, Jensen RB, Carlsen E et al. Increased basal and pulsatile secretion of FSH and LH in young men with 47,XXY or 46,XX karyotypes, Eur J of Endo, 2008; 158: 803-810. (Pubitemid 351837368)
98. Male breast cancer. W: Fentiman IS red. Detection and treatment of early breast cancer. Lippincott JB. Philadelphia 1990; 207-218.
99. Oya Y, Shigeto H, Ogawa M et al. Painful unilateral gynecomastia in a patient with myotonic dystrophy. Rinsho Shinkeigaku 2000; 40: 1047-1049. (Pubitemid 32294515)
100. Serrarrice G, Pellissier JF, Pouget J et al. Neuroendocrine syndrome: pseudomyopathic spinal amyotrophy with gynecomastia related to the X chromosome. Kennedy's syndrome. 3 cases. Presse Med 1987; 16: 299-302.
101. Ali F. e Medicine- Gynecomastia. Htm. Microsoft HTML. Document 4.0.
102. Whitcomb RW, Schimke RN, Kyner JL et al. Endocrine studies in a male patient with choriocarcinoma and gynecomastia. Am J Med 1986; 81: 917-920.
103. Dekker HM, de Jong IJ, Sanders J et al. Persistent Mullerian duct syndrome. Radiographics 2003; 23: 309-313. (Pubitemid 37431264)
104. Gillatt D. Antiandrogen treatments in locally advanced prostate cancer: are they all the same? J Cancer Res Clin Oncol 2006;132 (Suppl. 1): S17-S26. (Pubitemid 46360130)
105. Prezioso D, Pappagallo GL, Guazzoni G et al. QUABIOS Group. Hormonal treatment for prostate cancer in Italy. Preliminary data from a survey of the QUABIOS Group. Arch Ital Urol Androl 2006; 78: 15-19.
106. Prezioso D, Piccirillo G, Galasso R et al. Gynecomastia due to hormone therapy for advanced prostate. Cancer: a report of ten surgically treated cases and a review of treatment options. Tumori 2004; 90: 410-415.
107. Biju G, Taly AB, Sinha S et al. Painful gynecomastia following traumatic spinal cord injury. Clin Neurol Neurosurg 2005; 107: 442-443. (Pubitemid 40980395)
108. Heruti RJ, Dankner R, Berezin M et al. Gynecomastia following spinal cord disorder. Arch Phys Med Rehabil 1997; 78: 534-537. (Pubitemid 27212463)
109. Gooren LJG, Daantje CRE. Psychological stress as a cause of intermittent gynecomastia. Horm Metab Res 1986; 18: 424. (Pubitemid 16081965)
110. Aki FT, Tekin MI, Ozen H. Gynaecomastia as a complication of chemotherapy for testicular germ cell tumours. Urology 1996; 48: 944-946. (Pubitemid 26427108)
111. Smyth CM, Bremner WJ. Klinefelter's syndrome. Arch Intern Med 1998; 158: 1309-1314.
112. Aiman J, Brenner PF, MacDonald PC. Androgen and oestrogen production in elderly men with gynaecomastia and testicular atrophy after mumps orchitis. Clin Endocrinol Metab 1980; 50: 380-386. (Pubitemid 10161481)
113. Hershkovitz E, Leiberman E. Gynecomastia: a review. Endocrinologist. 2002; 12: 321-332. (Pubitemid 34790819)
114. Roehrborn C. Long-term consequences of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts. J Clin Endocrinol Metab 1999; 84: 4324-4331.
115. Wagenseil F. Chinese eunuchs. Z Morphol Anthropol 1933; 32: 415-468.
116. Biglia A. Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study. Clin Infect Dis 2004; 39: 1514-1519. (Pubitemid 39518217)
117. Edmondson HA, Glass SJ, Soll SN. Gynecomastia associated with cirrhosis of the liver. Proc Soc Exp Biol Med 1939; 42: 97-99.
118. Kley HK, Niederau C, Stremmel W et al. Conversion of androgens to estrogens in idiopathic hemochromatosis: comparison with alcoholic liver cirrhosis. J Clin Endocrinol Metab 1985; 61: 1-6. (Pubitemid 15046185)
119. Hershkovitz E, Leiberman E. Gynecomastia: a review. The Endocrinologist 2002; 12: 321-332. (Pubitemid 34790819)
120. Farthing MJ, Green JR, Edwards CR et al. Progesterone, prolactin, and gynaecomastia in men with liver disease. Gut 1982; 23: 276-279. (Pubitemid 12152742)
121. Van Thiel DH, McClain CJ, Elson MK et al. Hyperprolactinemia and thyrotropin-releasing factor (TRH) responses in men with alcoholic liver disease. Alcohol Clin Exp Res. 1978; 2: 344-348. (Pubitemid 9072606)
122. Merino AJ, Fluores TM, Izarzugaza LI et al. Recurrent thrombophlebitis and bilateral gynecomastia. Primary manifestations of hepatocarcinoma. Sem Hop 1984; 60: 580-582.
123. Meriggi F, Forni E. Surgical therapy of hepatic fibrolamellar carcinoma. Ann Ital Chir 2007; 78: 53-58.
124. Salles G, Vital Durand D, Mackiewicz R et al. Hepatocellular carcinoma and hyperestrogenia in a male. Gastroenterol Clin Biol 1987; 11: 607-609.
125. Zamd M, Farh M, Hbid O et al. Sexual dysfunction among 78 Moroccan male hemodialysis patients: clinical and endocrine study. Ann Endocrinol (Paris) 2004; 65: 194-200. (Pubitemid 39094923)
126. Hershkovitz E, Leiberman E. Gynecomastia: a review. The Endocrinologist 2002; 12: 321-332. (Pubitemid 34790819)
127. Caron P, Dueymes JM, Pourrat J et al. Gynecomastia and chronic renal insufficiency in periodic hemodialysis. Demonstration of a decrease in the free fraction of testosterone. Rev Med Interne 1984; 5: 110-113.
128. Gordon DL, Brown JL, Emanuele NV et al. Gynecomastia as the initial manifestation of hyperthyroidism. Endocr Pract 1997; 3: 80-81.
129. Ho HK, Loh KC. Hyperthyroidism with gynaecomastia as the initial complaint: a case report. Ann Acad Med Singapore 1998; 27: 594-596. (Pubitemid 128526601)
130. Tan YK, Birch CR, Valerio D. Bilateral gynaecomastia as the primary complaint in hyperthyroidism. J R Coll Surg Edinb 2001; 46: 176-177. (Pubitemid 32591326)
131. Ho HK, Loh KC. Hyperthyroidism with gynaecomastia as the initial complaint: a case report. Ann Acad Med Singapore 1998; 27: 594-596. (Pubitemid 128526601)
132. Castro-Magana M, Angulo M, Uy J. Elevated serum oestradiol associated with increased andro-stenedione-testosterone ratio in adolescent males with variocele and gynaecomastia. Fertil Steril 1991; 56: 515-518.
133. Hassan HC, Cullen IM, Casey RG et al. Gynaecomastia: an endocrine manifestation of testicular cancer. Andrologia 2008; 40: 152-157. (Pubitemid 351678541)
134. Jansen EP, Wagener DJ, Oosterhof GO. Gynecomastia in testicular tu- mors. Ned Tijdschr Geneeskd 1990; 134: 1745-1748.
135. Korenman SG. The endocrinology of the abnormal male breast. Ann NY Acad Sci 1986; 464: 400-408. (Pubitemid 17197646)
136. Xciarra A, Casale P, Di Nicola S et al. Hormonal profile of patients with Leydig cell tumors: a urologic cause of gynecomastia. Minerva Urol Nefrol 1998; 50: 225-231.
137. Tazi MF, Mellas S, El Fassi MJ et al. Leydig cell hyperplasia revealed by gynecomastia. Rev Urol 2008; 10: 164-167.
138. Bertola G, Giambona S, Balza G et al. An uncommon cause of gynecomastia: testicular Leydig cell tumor. Hormonal profile before and after orchiectomy Recenti Prog Med 2006; 97: 85-88.
139. Foppiani L, Bernasconi D, Del Monte P et al. Leydig cell tumour-induced bilateral gynaecomastia in a young man: endocrine abnormalities. Andrologie 2005; 37: 36-39. (Pubitemid 40175398)
140. Soriano GL, Pozo RJ, Muńoz C et al. Gynecomastia secondary to Leydig cell tumor. An Pediatr (Barc) 2003; 58: 67-70. (Pubitemid 36723137)
141. Rhoden EL, Morgentaler A. Case Report Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. Int J Impot Res 2004; 16: 95-97. (Pubitemid 38401569)
142. de Luis DA, Aller R, Cuéllar LA et al. Anabolic steroids and gynecomastia. Review of the literature. An Med Interna 2001; 18: 489-491.
143. Weinstein SP, Conant EF, Orel SG et al. Diabetic mastopathy in men: imaging findings in two patients. Radiology 2001; 219: 797-799. (Pubitemid 32476275)
144. Martínez-Ramos D, Alcalde-Sánchez M, Laguna-Sastre M et al. Diabetic mastopathy. Features in four patients. Cir Esp 2007; 81: 224-226.
145. Pfeilschifter J. Disordered hormone regulation in gynecomastia. Kongressbd Dtsch Ges Chir Kongr 2002; 119: 743-747.
146. Janes SE, Lengyel JA, Singh S et al. Needle core biopsy for the assessment of unilateral breast masses in men. Breast 2006; 15: 273-275.
147. Gusenoff JA, Coon D, Rubin JP. Pseudogynecomastia after massive weight loss: detectability of technique, patient satisfaction, and classification. Plast Reconstr Surg 2008; 122: 1301-1311.
148. Boring CC, Squires TS, Tony T et al. Cancer statistics, 1994. CA Cancer J Clinic 1994; 44: 7-26. (Pubitemid 24035713)
149. Kruś S, Skrzypek- Fakhoura E. red Patomorfologia Kliniczna. Wydawnictwo Lekarskie PZWL, Warszawa 1996.
150. Sandler B, Carman C, Perry RR. Cancer of the male breast. Am Surg 1994; 60: 816-820. (Pubitemid 24345713)
151. Joshi MG, Lee AKC, Loda M et al. Male breast carcinoma: an evaluation of prognostic factors contributing to poorer outcome. Cancer 1996; 77: 490-498. (Pubitemid 26047570)
152. Krause W. Male breast cancer - an andrological disease: risk factors and diagnosis. Andrologia 2004; 36: 346-354. (Pubitemid 39540772)
153. Chang HL, Kish JB, Smith BL et al. A 16-year-old male with gynecomastia and ductal carcinoma in situ. Pediatr Surg Int 2008; 24: 1251-1253.
154. Corroppolo M, Erculiani E, Zampieri N et al. Ductal carcinoma in situ in a 15-year-old boy with gynaecomastia: a case report. Pediatr Surg Int 2008; 24: 943-945.
155. Patterson SK, Helvie MA, Aziz K et al. Outcome of men presenting with clinical breast problems: the role of mammography and ultrasound. Breast J 2006; 12: 418-423. (Pubitemid 44337432)
156. Mathew J, Perkins GH, Stephens T et al. Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. AJR Am J Roentgenol 2008; 191: 1631-1639.
157. Jackson V, Gilmor R. Male breast carcinoma and gynecomastia: comparison of mammography with sonography. Radiology 1983; 149: 533-536.
158. Gupta RK, Naran S, Simpson J. The role of fine needle aspiration cytology (FNAQ in the diagnosis of breast masses in males. Eur J Surg Oncol 1988; 14: 317-320.
159. Czajka I, Zgliczyński W. Gynecomastia - pathogenesis, diagnosis and treatment. Pol J Endocrinol 2005; 56: 269-277.
160. Wiesman IM, Lehman JA, Parker MG et al. Gynecomastia: an outcome analysis. Ann Plast Surg 2004; 53: 97-101.